Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Other financing activities (2021 - 2025)

Historic Other financing activities for Biomerica (BMRA) over the last 4 years, with Q4 2025 value amounting to -$103000.0.

  • Biomerica's Other financing activities changed N/A to -$103000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $78000.0, marking a year-over-year change of. This contributed to the annual value of $84000.0 for FY2025, which is 370.37% up from last year.
  • Biomerica's Other financing activities amounted to -$103000.0 in Q4 2025.
  • Biomerica's Other financing activities' 5-year high stood at $652000.0 during Q2 2023, with a 5-year trough of -$103000.0 in Q4 2025.
  • Over the past 4 years, Biomerica's median Other financing activities value was $23476.0 (recorded in 2021), while the average stood at $72333.3.
  • Examining YoY changes over the last 5 years, Biomerica's Other financing activities showed a top increase of 15295164.32% in 2023 and a maximum decrease of 9427.46% in 2023.
  • Quarter analysis of 4 years shows Biomerica's Other financing activities stood at $29486.0 in 2021, then tumbled by 83.04% to $5000.0 in 2022, then soared by 12940.0% to $652000.0 in 2023, then plummeted by 115.8% to -$103000.0 in 2025.
  • Its Other financing activities stands at -$103000.0 for Q4 2025, versus $133000.0 for Q3 2025 and -$44000.0 for Q2 2025.